sj-pdf-1-cep-10.1177_03331024211053571 - Supplemental material for Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial

Reuter, Uwe; Ehrlich, Marc; Gendolla, Astrid; Heinze, Axel; Klatt, Jan; Wen, Shihua; Hours-Zesiger, Peggy; Nickisch, Jacqueline; Sieder, Christian; Hentschke, Christian; Maier-Peuschel, Monika

doi:10.25384/SAGE.16964617.v1

sj-pdf-1-cep-10.1177_03331024211053571.pdf (171.32 kB)

sj-pdf-1-cep-10.1177_03331024211053571 - Supplemental material for Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial

journal contribution

posted on 2021-11-09, 13:07 authored by Uwe Reuter, Marc Ehrlich, Astrid Gendolla, Axel Heinze, Jan Klatt, Shihua Wen, Peggy Hours-Zesiger, Jacqueline Nickisch, Christian Sieder, Christian Hentschke, Monika Maier-Peuschel

Supplemental material, sj-pdf-1-cep-10.1177_03331024211053571 for Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial by Uwe Reuter, Marc Ehrlich, Astrid Gendolla, Axel Heinze, Jan Klatt, Shihua Wen, Peggy Hours-Zesiger, Jacqueline Nickisch, Christian Sieder, Christian Hentschke and Monika Maier-Peuschel in Cephalalgia